Trial Profile
Double-blind Randomised Phase I/IIb Study
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Mar 2024
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus First in man; Pharmacokinetics
- Acronyms Compare
- Sponsors Celltrion
- 07 Aug 2019 Planned End Date changed from 1 Dec 2017 to 1 Dec 2020.
- 11 Feb 2015 Planned End Date changed from 1 Jun 2013 to 1 Dec 2017 according to ClinicalTrials.gov record.
- 04 Jun 2013 Status changed from active, no longer recruiting to completed.